Association of excision repair cross-complementation group 1 (ERCC1) gene expression (GE) with outcome in stage II-III esophageal adenocarcinoma (EA) patients treated with preoperative platinum-based chemoradiation (CRT) in a phase II cooperative group study (SWOG S0356).
P. O. Bohanes
No relevant relationships to disclose
B. H. Goldman
No relevant relationships to disclose
L. P. Leichman
No relevant relationships to disclose
C. D. Blanke
Consultant or Advisory Role - Sanofi
S. Iqbal
Consultant or Advisory Role - Sanofi
C. R. Thomas
No relevant relationships to disclose
C. L. Corless
No relevant relationships to disclose
K. G. Billingsley
No relevant relationships to disclose
K. D. Danenberg
Employment or Leadership Position - Response Genetics
W. Zhang
No relevant relationships to disclose
J. K. Benedetti
No relevant relationships to disclose
P. J. Gold
No relevant relationships to disclose
H. Lenz
Stock Ownership - Response Genetics